Antiviral drug, Favipiravir, could kill SARS-CoV-2 viral genome
CSSB Scientific Director, Chris Meier (UHH), and his postdoc Johanna Huchting were involved in a collaborative study with researchers from AFMB-CNRS, the University of Aix-Marseille, Universität Hamburg, and Colorado State University that reported the first detailed kinetic and mechanistic analysis of SARS-CoV-2's polymerase enzyme.
Read more